MedPath

To study the clinical effect of Shelshsmatakadya Agad & Edagajadi lepa in dermatophytosis

Phase 2
Conditions
Health Condition 1: L089- Local infection of the skin and subcutaneous tissue, unspecified
Registration Number
CTRI/2021/10/037151
Lead Sponsor
Dr Trupti Mahapatra
Brief Summary

Not available

Detailed Description

Not available

Recruitment & Eligibility

Status
ot Yet Recruiting
Sex
Not specified
Target Recruitment
0
Inclusion Criteria

1.Patients of age group between 18-60 years irrespective of sex, religion, socioeconomic status will be taken into consideration.

2.All the patients of Dushi visha janit twak vikar w.s.r.to Dadru presenting symptoms like Kandu, Raga, Pidika, Mandala will be included for clinical trial.
3.Willing Patients to sign consent form.

Exclusion Criteria

1.Patient of burn, severe allergic disease, psoriasis, leprosy, measles, herpes, chicken pox, leukoderma, carcinoma, SLE (systemic lupus erythematous), pregnant women, Lactating women, Pediatrics Age Group.

2.Patients suffering from any severe or complicated systemic disease like diabetes mellitus, renal disease, liver disease, VDRL, will be excluded from trail.

Study & Design

Study Type
Interventional
Study Design
Not specified
Primary Outcome Measures
NameTimeMethod
comparing the effect of Shleshmatakadya Agad and Edagajadi Lepa in dermatophytosis before and after intervention.at 7weeksTimepoint: comparing the effect of Shleshmatakadya Agad and Edagajadi Lepa in dermatophytosis before and after intervention.at 7weeks
Secondary Outcome Measures
NameTimeMethod
change in subjective and objective parameters after the treatment.Timepoint: at the end of 3 month
© Copyright 2025. All Rights Reserved by MedPath